{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-031101","form_type":"8-K","ticker":"PROK","cik":"0001850270","company_name":"PROKIDNEY CORP.","filed_at":"2023-06-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.226760+00:00","generated_at":"2026-06-13T14:21:34.665425+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"ProKidney elects three directors, ratifies Ernst & Young as auditor","bullets":["Elected directors William F. Doyle, Alan M. Lotvin, and Brian J.G. Pereira to three-year terms with over 204.6M votes each (>99.9% of votes cast).","Ratified Ernst & Young as independent auditor for FY 2023: 211,255,952 for, 15,231 against, 234 abstain.","Broker non-votes totaled 6,436,976 on director elections; all proposals passed."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-031101","json":"https://secwatch.observer/filing/0000950170-23-031101.json","markdown":"https://secwatch.observer/filing/0000950170-23-031101.md","text":"https://secwatch.observer/filing/0000950170-23-031101.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850270/000095017023031101/0000950170-23-031101-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850270/000095017023031101/prok-20230629.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T14:21:34.665425+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"23688b10a0ea9e96bc5aa48458b1904d5686500c","claim":"PROKIDNEY CORP. shareholders approved Election of Directors for a three-year term expiring in 2026 at the 2023-06-29 meeting.","evidence_excerpt":"Based on the following results of the voting, the Company’s shareholders elected the nominees listed below to the Company’s Board of Directors, each to serve for a three-year term to expire at the Company’s annual general meeting of shareholders in 2026 and until their successors are duly elected and qualified: Director Nominee  For  Against  Abstain Broker Non Votes William F. Doyle  204,688,357  86,755  59,329  6,436,976 Alan M. Lotvin, M.D.  204,717,013  86,192  31,236 6,436,976 Brian J. G. Pereira, M.D.  204,658,435  84,994  91,012  6,436,976","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017023031101/0000950170-23-031101-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-29"}],"fact_type":"shareholder_vote"},{"claim_id":"5c2dd4b959aeb30abf487bb9417c160e57f5f51a","claim":"PROKIDNEY CORP. shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year 2023 at the 2023-06-29 meeting.","evidence_excerpt":"The appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023, was ratified based on the following results of the voting: For  Against  Abstain Broker Non Votes 211,255,952  15,231  234","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017023031101/0000950170-23-031101-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-29"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}